Cognition Therapeutics (CGTX) Stock Chart & Stock Price History $0.39 +0.04 (+11.65%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cognition Therapeutics Stock Price Performance 5 Day Performance+20.45%1 Month Performance-11.94%3 Month Performance-44.82%6 Month Performance-7.60%Year-To-Date Performance-43.82%1 Year Performance-79.90% Receive CGTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address CGTX Stock Chart for Monday, April, 14, 2025 CGTX Chart by TradingViewRemove Ads Cognition Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/14/2025$0.35$0.39+11.65%$0.40$0.36689,945 shs$24.42 million04/11/2025$0.32$0.35+10.49%$0.36$0.32316,919 shs$21.87 million04/10/2025$0.33$0.32-2.35%$0.34$0.31360,443 shs$19.79 million04/09/2025$0.32$0.33+1.96%$0.35$0.311.20 million shs$20.27 million04/09/2025$0.32$0.33+1.96%$0.35$0.311.20 million shs$20.27 million04/08/2025$0.35$0.32-7.55%$0.36$0.32400,327 shs$19.88 million04/08/2025$0.35$0.32-7.55%$0.36$0.32400,327 shs$19.88 million04/07/2025$0.35$0.35-2.03%$0.36$0.31732,059 shs$21.51 million04/04/2025$0.39$0.35-8.24%$0.39$0.34979,530 shs$21.95 million04/03/2025$0.41$0.39-6.51%$0.40$0.38439,210 shs$23.92 million Get the Latest News and Ratings for CGTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/02/2025$0.39$0.41+5.30%$0.42$0.38331,040 shs$25.59 million04/01/2025$0.42$0.39-6.82%$0.44$0.391.81 million shs$24.30 million03/31/2025$0.42$0.42+1.23%$0.43$0.39454,185 shs$26.08 million03/28/2025$0.45$0.42-7.77%$0.45$0.41430,544 shs$17.27 million03/27/2025$0.44$0.45+2.06%$0.45$0.43250,367 shs$18.73 million03/26/2025$0.46$0.44-3.85%$0.49$0.43528,835 shs$18.35 million03/25/2025$0.49$0.46-6.23%$0.50$0.45660,478 shs$19.08 million03/24/2025$0.45$0.49+7.67%$0.49$0.45921,207 shs$20.35 million03/21/2025$0.43$0.45+6.61%$0.47$0.42561,405 shs$18.90 million03/20/2025$0.45$0.43-5.18%$0.47$0.41793,504 shs$17.73 million03/19/2025$0.44$0.45+2.25%$0.46$0.43443,864 shs$18.70 million03/18/2025$0.45$0.44-1.52%$0.47$0.44304,303 shs$18.29 million03/17/2025$0.45$0.45-0.11%$0.47$0.44474,055 shs$18.57 million03/14/2025$0.42$0.45+7.81%$0.45$0.42362,880 shs$18.59 million03/13/2025$0.42$0.42-2.19%$0.46$0.41941,919 shs$17.24 million Related Companies Oramed Pharmaceuticals Stock Chart Immunic Stock Chart Climb Bio Stock Chart CervoMed Stock Chart Galectin Therapeutics Stock Chart Atossa Therapeutics Stock Chart Zentalis Pharmaceuticals Stock Chart Editas Medicine Stock Chart Neoleukin Therapeutics Stock Chart Kyverna Therapeutics Stock Chart Receive CGTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CGTX) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cognition Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cognition Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CGTX Stock Free CGTX Stock Alerts